A strategy for producing predicted polymorphs : catemeric carbamazepine form V

Arlin, Jean-Baptiste and Price, Louise S and Price, Sarah L and Florence, Alastair J (2011) A strategy for producing predicted polymorphs : catemeric carbamazepine form V. Chemical Communications, 47 (25). pp. 7074-7076.

Preview

PDF Florencec1cc11634g.pdf Final Published Version Download (1MB)| Preview

Abstract

A computationally assisted approach has enabled the first catemeric polymorph of carbamazepine (form V) to be selectively formed by templating the growth of carbamazepine from the vapour phase onto the surface of a crystal of dihydrocarbamazepine form II.

ORCID iDs

Florence, Alastair J ORCID: https://orcid.org/0000-0002-9706-8364

• Share and Export
  

  RDF+XMLBibTeXRIOXX2 XMLRDF+N-TriplesJSONDublin CoreAtomSimple MetadataReferMETSArchivematicaHTML CitationASCII CitationOpenURL ContextObjectEndNoteOpenURL ContextObject in SpanMODSMPEG-21 DIDLEP3 XMLData Cite XMLRIS (EndNote Online, Zotero, Ref manager, etc)RDF+N3Multiline CSV
• Citations and altmetrics
• Item metadata

  Item type:	Article
  ID code:	33062
  Dates:	Date Event 26 May 2011 Published
  Notes:	This journal is © The Royal Society of Chemistry 2011
  Keywords:	polymorphs, catemeric carbamazepine, catemeric polymorph , vapour phase , crystal , Pharmacy and materia medica, Materials Chemistry, Surfaces, Coatings and Films, Metals and Alloys, Ceramics and Composites, Chemistry(all), Catalysis, Electronic, Optical and Magnetic Materials
  Subjects:	Medicine > Pharmacy and materia medica
  Department:	Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Technology and Innovation Centre > Continuous Manufacturing and Crystallisation (CMAC)
  Depositing user:	Pure Administrator
  Date deposited:	30 Aug 2011 13:05
  Last modified:	31 Jul 2021 02:22
  URI:	https://strathprints.strath.ac.uk/id/eprint/33062